Overview of How science is taking tripping mainstream
This NPR Shortwave episode explains how psychedelic drugs moved from counterculture symbols and heavily restricted substances to serious subjects of psychiatric research. The central story is a scientific and cultural shift: over the last two decades, researchers have built evidence that compounds like psilocybin, LSD, MDMA, DMT, and ibogaine may help treat depression, PTSD, addiction, and other mental health conditions. The episode highlights the role of Imperial College London in legitimizing this work and shows how careful clinical protocols, brain imaging, and promising trial results helped bring psychedelics into the medical mainstream.
Why psychedelics are being taken seriously now
From prohibition to renewed research
- Psychedelics were long associated with the 1960s counterculture and treated as dangerous rather than therapeutic.
- Research largely stalled after the Nixon-era crackdown on psychedelic drugs.
- In the early 2000s, scientists began revisiting these substances with modern neuroscience tools.
What changed
- Researchers started asking not whether psychedelics were culturally controversial, but whether they could help people with serious psychiatric disorders.
- Evidence accumulated that these drugs may reduce symptoms of:
- depression
- PTSD
- anxiety disorders
- addiction
- anorexia
Broader social acceptance
- Public attitudes shifted as the science became more rigorous.
- The episode notes that even U.S. political leadership has begun signaling interest in speeding evaluation of psychedelic treatments for psychiatric use.
The scientists who helped move the field forward
Early leaders in psychedelic neuroscience
The episode names several key researchers who helped legitimize the field:
- Roland Griffiths at Johns Hopkins
- David Nutt at the University of Bristol / Imperial College London
- Robin Carhart-Harris, now at UCSF
- Dr. David Erritzoe (referred to in the transcript as “Aritzo”), a psychiatrist who helped lead early studies
Imperial College London’s role
- Imperial became a major hub for psychedelic research.
- Carhart-Harris and Erritzoe conducted one of the first formal studies using psilocybin to treat depression.
- Their work helped establish psychedelics as a legitimate topic for serious clinical investigation.
- The team’s studies later appeared in top journals, including the New England Journal of Medicine.
What the brain research found
Psilocybin and the default mode network
One of the episode’s key neuroscience findings is that psilocybin appears to disrupt the brain’s default mode network:
- This network is active during daydreaming and self-referential thought.
- It is linked to a person’s sense of self.
- Its temporary breakdown may help explain why people on psychedelics:
- see themselves differently
- reframe traumatic experiences
- feel less trapped in rigid thought patterns
Imaging and behavioral studies
- The Imperial team used advanced brain imaging alongside human studies.
- Their work showed that psychedelics change how the brain functions, not just how people feel in the moment.
Why ketamine mattered too
A legal bridge to psychedelic-style therapy
- Ketamine is not a classic psychedelic; it’s a dissociative.
- But it can create a similar window of rapid brain change and therapeutic openness.
- Because ketamine had long been used as an anesthetic, it was easier to study legally.
Clinical impact
- About 20 years ago, NIH researchers found ketamine could help people with treatment-resistant depression.
- In 2019, the U.S. and U.K. approved a nasal spray form of ketamine for depression.
- This helped normalize the idea that altered states of consciousness could have medical value.
How psychedelic therapy is actually done
“Set and setting”
The episode emphasizes that psychedelic treatment is not just about giving someone a drug:
- Patients are psychologically prepared beforehand.
- The drug is given under supervision.
- Treatment happens in a carefully designed room meant to feel calm and comforting.
The therapeutic environment
- The room is intentionally unlike a sterile hospital space.
- It may include:
- soft lighting
- drapes
- mood lamps
- incense
- relaxing music
Music as a “hidden therapist”
- The researchers developed playlists to guide the experience.
- Music is described as a crucial, almost therapeutic presence in the session.
- An actual therapist is also present to discuss the patient’s depression, trauma, or addiction.
Main takeaway
The episode argues that psychedelic medicine is becoming mainstream because the evidence is getting stronger, the clinical methods are more sophisticated, and institutions now view these drugs as potential treatments rather than cultural threats. The result is a new model of care that combines neuroscience, psychotherapy, and carefully supervised altered states—an approach that may soon become more common in mental health clinics.